“…The presence of other RAassociated pulmonary disease, such as bronchiectasis or rheumatoid lung nodules, may predispose the patient to infection by providing a portal of entry to the pleural space-for instance through the rupture and formation of a bronchopleural fistula. 20 It may be necessary to review any prescribed immunosuppression therapy; whereas conventional wisdom dictates that treating RA reduces the risk of progressive pulmonary disease, excessive immunosuppression therapy may make treating an infection impossible. Furthermore, continuing treatment with any drug having an anti-inflammatory effect may negatively impact on the likelihood of successful pleurodesis following treatment for empyema or pneumothorax, 21,22 with talc preferable to complete pleurectomy, decortications, or other chemical agents.…”